News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Newer Diabetes Drugs Cost More, But May Not Work Better, University of Michigan, Mayo Clinic And North Carolina State University Study


2/28/2014 7:48:18 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Two newer classes of drugs to treat adult-onset diabetes may be no more effective than the old standby, yet they cost significantly more over the course of a patient’s disease. That’s according to a National Science Foundation-funded study by researchers at the University of Michigan, Mayo Clinic and North Carolina State University.

Hey, check out all the research scientist jobs. Post your resume today!


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES